|
|
楼主 |
发表于 11-5-2009 11:55 PM
|
显示全部楼层
原帖由 bennywt 于 11-5-2009 11:23 PM 发表 
我也买到了，USD1.33，2lot。
2lot....= 200unit?
欢迎 加入 CTIC 。。。我们都是股东。。。 |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 12:44 AM
|
显示全部楼层
我也上车了，500 @ 1.41. |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 07:10 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 08:58 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 09:20 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 10:39 AM
|
显示全部楼层
好消息？
http://www.xconomy.com/seattle/2009/...-892m-in-debt/
Cell Therapeutics Raises $20M from Single Investor, Hopes to Unload $89.2M in Debt
Luke Timmerman 5/11/09
[[Update with corrected Zevalin sale price]] Cell Therapeutics is trying to get rid of a major load of debt. The Seattle biotech company said today it has sold $20 million worth of common stock and warrants to buy stock to a single unnamed institutional investor. It hopes to swap some of that money, along with the $17.8 million in cash it currently has, along with some of its common stock, to wipe out about $89.2 million of its debt that starts coming due as early as next year.
The company (NASDAQ: CTIC) has been carrying around more than that, about $120 million of debt, on its balance sheet for years. It borrowed the money back in the days when it had high hopes that its modified form of paclitaxel, a chemotherapy drug, would succeed in clinical trials, and become a big seller. That was supposed to allow the debt to convert into shares, so that the company would never have to pay back the principal. But that drug failed in pivotal clinical trials, driving down Cell Therapeutics stock, and leaving the company on the hook to make debt payments without a blockbuster moneymaking product.
Back in February, CEO James Bianco said it would take a “high-wire act” over the next six months to keep the company moving ahead, and that’s apparently what he’s been doing. The company closed down an Italian research center, eliminating more than 60 jobs, sold off its stake in its lone marketed product, ibritumomab tiuxetan (Zevalin) to Spectrum Pharmaceuticals for $31.5 million, and then sold shares to Cranshire Capital for an offering that grossed $23.8 million. All those maneuvers have enabled the company to stretch out its cash reserves to operate into August, to buy some time while it whips up an application to the FDA for another experimental cancer that has sparked high hopes—pixantrone for non-Hodgkin’s lymphoma.
Today’s deal is evidently one of several moves the company needs to execute to start building more value from the progress of pixantrone. The drug showed an ability in a clinical trial of 140 patients to completely eliminate tumors in about 20 percent of patients, compared with 5.7 percent who did that well in a control group, although there were more instances of “severe cardiac events” in the group who got pixantrone. Full details will be presented at the American Society of Clinical Oncology meeting in Orlando, FL, later this month, the company has said.
While the company assembles its application, the Swiss drug giant Novartis is doing its due diligence on the drug. If Novartis decides to exercise an option to co-market the product, it could pay Cell Therapeutics a $7.5 million fee. That could lead to a total of $40 million in milestone payments in 2009, Bianco said earlier this year in an investor presentation. Novartis could pay the bills for commercializing the product, and leave Cell Therapeutics with a double-digit percentage royalty on sales, he said.
Cell Therapeutics said it currently has about $118.9 million in debt outstanding, and that it hopes to exchange cash to get rid of $89.2 million in the near future. The company expects to offer investors cash and stock in the range of $250 to $300 for every $1,000 increment of debt securities they hold.
“The company believes that reducing its outstanding indebtedness is necessary in order for its business to operate in light of the current asset base and revenue projections,” the company said in a statement. |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 11:01 AM
|
显示全部楼层
他只是讲述ctic如何面对亏损。。。
他的pixantrone不止是NHL的救命药物，也是CTIC的救命药物。感觉他们会不折手段，保住这间公司，直到这个药物出现在market。 |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 12:27 PM
|
显示全部楼层
谢谢搂主介绍的这支好股。
我几个月前就注意他了。不过没有信心。
想不到真的冲上来了。
我也在观察DRYS..
目前我要寻找日后带来2000% 的小股。
发不发就看这次了。。。
希望大家把好股介绍上来 |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 01:30 PM
|
显示全部楼层
From Google Finance Discussions
This is sexy as hell.
(Taken from Barchart.com)
Trend Spotter TM Buy
Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Buy
20 Day Bollinger Bands Buy
Short Term Indicators Average: 100% - Buy
20-Day Average Volume - 34462301
Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy
50-Day Average Volume - 25700193
Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy
100-Day Average Volume - 16381004
Overall Average: 100% - Buy
Price Support Pivot Point Resistance
1.62 1.03 1.49 1.95 |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 01:43 PM
|
显示全部楼层
可參考下：
http://papergains.blogspot.com/2009/05/new-improved-fda.html
Looking for the next big thing? So are we. Here's a running list of potential winners.
[ 本帖最后由 葉芬 于 12-5-2009 01:45 PM 编辑 ] |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 01:58 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 02:31 PM
|
显示全部楼层
原帖由 napster 于 12-5-2009 01:58 PM 发表 
is that CTIC?
對。
谢谢你的用心分享。、很有用。
我打算在六月来个交流会，在新加坡，希望大家 ...
可惜，我七月才會去新加坡，七號至十一號。
希望下次還有機會。 |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 02:54 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 03:03 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 12-5-2009 08:34 PM
|
显示全部楼层
原帖由 napster 于 12-5-2009 12:27 PM 发表 
谢谢搂主介绍的这支好股。
我几个月前就注意他了。不过没有信心。
想不到真的冲上来了。
我也在观察DRYS..
目前我要寻找日后带来2000% 的小股。
发不发就看这次了。。。
...
你也是 DRYS的股東
？哈哈哈哈。。。。。這3天
下的太快。。。。10。6 的時候 想放。。可是 貪心
。。
我很喜歡這股。。。。可是 dilute 了。。。。 |
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 12-5-2009 08:40 PM
|
显示全部楼层
原帖由 napster 于 12-5-2009 12:27 PM 发表
谢谢搂主介绍的这支好股。
我几个月前就注意他了。不过没有信心。
想不到真的冲上来了。
我也在观察DRYS..
目前我要寻找日后带来2000% 的小股。
发不发就看这次了。。。
...
謝謝？ 不敢當。。。大家切磋／交換意見。。
我不久前才開始 買股。。。算是新鳥。。。
覺得ctic 真的很有潛力。。。要就大好， 要就大壞！！
好可能上 百翻。。。不好。。。沒人能預料。。。。不過近期看來 是越來越不錯。。
沒急用錢 就買來 hold。。。 |
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 12-5-2009 09:08 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 10:47 PM
|
显示全部楼层
大家还好吗？
有没有被吓到。
从中午到现在，我自我分析好几个penny stock,
觉得价钱有些高了。
要博是可以，不过要hold 一段日子，对我来说时间就是钱，（我的contra limit 对我来说很重要，所以我尽量让trust account 有多点钱），可能我不会先进去。
第一考虑进场的有GNTA....买上来，不看它。6个月看一次。可能一不小心，ei...成为百万富翁了。 |
|
|
|
|
|
|
|
|
|
|
|
楼主 |
发表于 12-5-2009 11:09 PM
|
显示全部楼层
原帖由 napster 于 12-5-2009 10:47 PM 发表
大家还好吗？
有没有被吓到。
从中午到现在，我自我分析好几个penny stock,
觉得价钱有些高了。
要博是可以，不过要hold 一段日子，对我来说时间就是钱，（我的contra limit 对我来说很重要，所以我尽量让 ...
hahaha ..
how many share u own for GNTA? |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-5-2009 11:22 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
1830 
37
